文献速递角膜与眼表疾病

角膜染色应答分析:干眼症临床有意义的结局指标

Corneal Staining Responder Analysis: A Clinically Meaningful Dry Eye Outcome.
PubMed 文献 · Ophthalmology · 2025-07-24

该研究回顾性分析了4项大型随机对照研究中的1704例蒸发型或水液缺乏型干眼症成人患者,评估角膜点状上皮糜烂与患者报告症状的相关性。角膜染色应答定义为染色评分较基线改善≥3级,结果显示应答者在所有评估症状上的改善数值上均大于非应答者,且75%的比较中差异有统计学意义。结论认为角膜染色评分改善≥3级与症状改善显著相关,可能作为临床研究和患者护理中有意义的干眼症结局指标。

要点

  • 角膜染色应答定义为荧光素染色评分较基线改善≥3级。
  • 在4项研究中,应答者所有干眼症状改善在数值上均大于非应答者。
  • 75%的症状比较中,应答者的症状改善显著大于非应答者。

核心结论

  • 角膜染色评分改善≥3级与相应的症状改善持续相关,可能代表临床研究和患者护理中有临床意义的干眼症结局指标。

研究设计与样本

  • 回顾性分析先前发表的4项大型随机对照研究,共纳入1704例蒸发型或水液缺乏型干眼症成人患者,评估两种干眼药物(无水环孢素0.1%溶液和全氟己基辛烷滴眼液)或各自对照(赋形剂和生理盐水)的效果。

主要发现

  • 在所有4项研究中,角膜染色应答者在所有评估的干眼症状上改善数值上均大于非应答者。
  • 共进行36项比较,涉及14种不同的干眼症状,其中75%的比较中应答者的症状改善显著大于非应答者。
  • 该发现与所接受的治疗、患者人口学特征以及干眼症的严重程度或类型无关,在4项研究中一致。

关键数值与推荐

  • 角膜点状上皮糜烂使用荧光素染料评估,染色评分按美国国家眼科研究所量表(0-15)分级。
  • 角膜染色应答定义为基于已发表文献和专家意见的染色评分较基线改善≥3级。
  • 患者症状使用视觉模拟量表(0-100)评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Thus far, clinical studies related to dry eye disease (DED) have focused on demonstrating a statistically significant difference in various ocular surface and tear film parameters and patient symptoms between the test arm versus comparator. However, it is largely unclear what arm differences or magnitude of improvement for a given parameter are clinically meaningful. This study aims to assess the correlations between corneal punctate erosions and patient-reported symptoms and aims to define "corneal staining responder" as a physician-measured and clinically meaningful DED outcome to be used in clinical studies and patient care. DESIGN: Retrospective analysis of previously published studies. PARTICIPANTS: A total of 1704 adult patients with evaporative or aqueous deficient DED who participated in 4 large-scale randomized, controlled studies evaluating 2 different DED medications (a water-free cyclosporine 0.1% solution and perfluorohexyloctane ophthalmic solution) or their respective comparators (vehicle and saline solution). METHODS: Corneal punctate epithelial erosions were evaluated using fluorescein dye, and the staining score was graded according to the National Eye Institute scale (0-15). "Corneal staining responder" was defined as a ≥3 grade improvement from baseline, based on published literature and expert opinion. A variety of patient symptoms were assessed using a visual analogue scale (0-100). MAIN OUTCOME MEASURE: Corneal staining responders were compared with nonresponders regarding improvement in symptoms via analysis of covariance irrespective of the treatment received. RESULTS: In all 4 studies, corneal staining responders showed numerically greater improvement in all assessed DED symptoms compared with nonresponders. Overall, 36 comparisons were performed involving 14 different DED symptoms. In 75% of the comparisons, the magnitude of the symptom improvement in responders was statistically significantly greater compared with nonresponders. This finding was consistent across all 4 studies, irrespective of the treatment applied, the patient demographics, and the severity or type of DED. CONCLUSIONS: This analysis demonstrates that a ≥3 severity grade improvement in corneal staining score is consistently associated with significant corresponding symptom improvement and may represent a clinically meaningful DED outcome measure for clinical studies and patient care. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Akpek EK, Sheppard JD, Krösser S, et al. Corneal Staining Responder Analysis: A Clinically Meaningful Dry Eye Outcome. Ophthalmology. 2025. PMID: 40714162. doi:10.1016/j.ophtha.2025.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。